Table 1.
Stratification and treatment of the cohort.
| Fraction of total | Percentage | |
|---|---|---|
| Gender (male/female) | 69/59 (128) | 54/46 |
| Diagnosis | B lineage: 107; T-lineage: 13; Ph positive: 3; biphenotypic: 2; mature B-lineage: 3 |
83.6/10.2/2.3/1.6/2.3 |
| Risk-group (nonHR/HR) | 92/36 (128) | 71.9/28.1 |
| CNS status (1/2/3) | 97/21/7 (125) | 77.6/16.8/5.6 |
| Bone marrow transplant (BMT) | 26/128 | 20.3 |
| Relapse | 19/128 (19 patients; 20 relapses) | 14.8 |
| Graft-vs.-host disease (GvHD) | 18/128 | 14.1 |
| Total body irradiation only | 17/128 | 13.3 |
| Cranial irradiation only | 11/128 | 8.6 |
| Total body irradiation and cranial irradiation | 5/128 | 3.9 |
Total numbers or fractions are displayed as well as the percentage for gender, diagnosis, risk-group [Non-high risk (nonHR) vs. high risk (HR)], central nervous system involvement (CNS Status; 1, negative; 2, low level leukemic blasts in spinal tab; 3, CNS disease), bone marrow transplant (BMT), relapse, graft-vs.-host disease (GvHD) of all grades, total body irradiation and cranial irradiation.